clinical-stage

CerSci

Dallas-based Biotech CerSci Acquired by ACADIA Pharmaceutical in $52.5M Deal

by | Aug 25, 2020
CerSci shareholders could net another $887 million in milestones and tiered royalties. The clinical-stage startup, which launched in 2015, is developing a new generation of non-opioid meds to treat acute and chronic pain.
MORE
Southlake BioTech Startup Gets $10M Grant from CPRIT for Technology That ‘Lights Up’ Cancer
by | Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE
Clinical-Stage Biotech Expands From Silicon Valley to the University of North Texas Health Science Center in Fort Worth
by | Jul 13, 2020
CAGE Bio—currently a resident at Johnson & Johnson Innovation—uses a proprietary platform to develop therapeutic products for dermatology, inflammation, and immunology.
MORE